highperformr logo

Orum Therapeutics's Overview

Total employees47
HeadquartersCambridge
Founded2016

Orum Therapeutics is a private, clinical-stage biotechnology company focused on revolutionizing cancer treatment through the development of novel tumor-selective, targeted protein degraders (TPDs). Their proprietary Oromab™ platform combines the cell-specific delivery of antibodies with the potent cell-killing mechanism of protein GSPT1 degradation. This approach aims to create highly effective therapies with improved safety profiles for hard-to-treat cancers. Orum's pipeline includes candidates for solid tumors and hematologic malignancies, with ongoing clinical trials.

Where is Orum Therapeutics's Headquarters?

HQ Function

The Cambridge headquarters serves as the central hub for corporate strategy, business development, clinical operations leadership, investor relations, and global program management.

Notable Features:

Located within the Cambridge Innovation Center (CIC), providing access to state-of-the-art facilities, flexible workspaces, and a vibrant community of innovators and entrepreneurs.

Work Culture:

The work culture is characterized by a strong emphasis on scientific rigor, innovation, and collaboration. As a clinical-stage biotech, the environment is dynamic, fast-paced, and mission-driven, focused on advancing treatments for patients.

HQ Significance:

Its location in Kendall Square places Orum at the epicenter of the biotech world, offering unparalleled access to leading academic institutions, research talent, potential partners, and investors.

Values Reflected in HQ: The headquarters' location and setup reflect Orum's commitment to cutting-edge science, innovation, global collaboration, and strategic growth in the competitive biopharmaceutical landscape.

Location:

Orum Therapeutics operates with a global mindset, leveraging its dual presence in the USA and South Korea. The Cambridge, MA headquarters manages global clinical development, strategic partnerships, and business operations, while the Daejeon R&D center drives discovery and innovation. This structure allows Orum to access global talent, engage with international research communities, and conduct clinical trials across different regions to bring its cancer therapies to patients worldwide.

Street Address:

One Broadway, 14th Floor

City:

Cambridge

State/Province:

MA

Country:

USA

Orum Therapeutics's Global Presence

Daejeon, Republic of Korea

Address: Bio-Innovation Complex, 60, Daehak-ro 4-gil, Yuseong-gu, Daejeon 34134, Republic of Korea

Leverages South Korea's advanced biotech infrastructure, skilled scientific talent pool, and supportive R&D environment to drive early-stage innovation and pipeline development.

Buying Intent Signals for Orum Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Orum Therapeutics

As of April 2025, Orum Therapeutics' leadership includes:

Sung Joo Lee, Ph.D. - Founder & Chief Executive Officer
Peter U. Park, Ph.D. - Chief Scientific Officer
Jacob S. Lee, M.D., M.B.A. - Chief Medical Officer
Michael Jang - Chief Financial Officer
Jamesiria (Jamie) Han, M.S. - Chief Operating Officer

Investors of Orum Therapeutics

Orum Therapeutics has been backed by several prominent investors over the years, including:

IMM Investment
InterVest
KB Investment
Smilegate Investment
Stassets Investment
KDB Capital
Korea Investment Partners
LB Investment
Samsung Venture Investment Corporation

Executive New Hires/Exits in the Last 12 Months

Hire3
Exits1

Orum Therapeutics has significantly strengthened its leadership team over the past year with key C-suite appointments to drive its clinical and operational growth.

Departures

Ilhan Kim, Ilhan Kim departed from his role as Chief Financial and Strategy Officer.

New Appointments:

Michael Jang, Michael Jang was appointed as the new Chief Financial Officer.
Jamesiria (Jamie) Han, M.S., Jamesiria (Jamie) Han was appointed as the new Chief Operating Officer.
Jacob S. Lee, M.D., M.B.A., Dr. Jacob S. Lee was appointed as the new Chief Medical Officer.

Technology (Tech Stack) used by Orum Therapeutics

Discover the tools Orum Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Orum Therapeutics Email Formats and Examples

Common email formats for Orum Therapeutics likely follow standard professional patterns. While not publicly confirmed, a frequent structure used by similar companies is [first_initial][last]@orumrx.com.

[first_initial][last]@orumrx.com

Format

jdoe@orumrx.com

Example

70%

Success rate

News and media

Orum TherapeuticsMay 15, 2024

Orum Therapeutics Presents Preclinical Data on ORM-5029 and ORM-6151 at the 2024 TPD Summit

Orum Therapeutics announced it presented preclinical data from two programs, ORM-5029 and ORM-6151, at the 5th Annual GSPT1-Focused Targeted Protein Degradation (TPD) Summit. The data highlighted the potential of its GSPT1 degraders using the Oromab™ platform for treating HER2-expressing solid tumors and AML....more

Orum TherapeuticsJanuary 4, 2024

Orum Therapeutics Doses First Patient in Phase 1 Trial of ORM-6151 for Acute Myeloid Leukemia

Orum Therapeutics announced the dosing of the first patient in its Phase 1 clinical trial evaluating ORM-6151 for the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS)....more

Orum TherapeuticsJuly 11, 2023

Orum Therapeutics Appoints Jacob S. Lee, M.D., M.B.A., as Chief Medical Officer

Orum Therapeutics announced the appointment of Jacob S. Lee, M.D., M.B.A., as its Chief Medical Officer. Dr. Lee brings over 20 years of experience in oncology drug development to lead Orum's clinical strategy and operations....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Orum Therapeutics, are just a search away.